Managing High‐Risk Patients With Hypertension: Focus on the Renin‐Angiotensin System
Author:
Affiliation:
1. From the Division of Cardiovascular Diseases, Western Pennsylvania Hospital (Clinical Campus) and Temple University School of Medicine, Pittsburgh, PA
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1524-6175.2004.03524.x
Reference37 articles.
1. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2. Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
3. Results of the ALLHAT Trial: Is the Debate About Initial Antihypertensive Drug Therapy Over?
4. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report
5. A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups;Vascular Health and Risk Management;2015-01
2. SIMULTANEOUS DETERMINATION AND PHARMACOKINETIC STUDY OF AMLODIPINE AND VALSARTAN IN RAT PLASMA USING ION-PAIR HPLC WITH FLUORESCENCE DETECTION;Journal of Liquid Chromatography & Related Technologies;2013-06
3. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet;Heart and Vessels;2010-10-05
4. Angiotensin-Converting Enzyme Inhibitors;Comprehensive Hypertension;2007
5. Hypertension and atherosclerosis: Clinical implications from the ALLHAT trial;Current Atherosclerosis Reports;2005-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3